{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:27:46Z","timestamp":1760027266104,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12872-017-0503-8","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T19:25:17Z","timestamp":1487791517000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Findings of transoesophageal echocardiogram in appropriately anticoagulated patients with persistent atrial fibrillation prior to planned cardioversion"],"prefix":"10.1186","volume":"17","author":[{"given":"J\u016brat\u0117","family":"Barysien\u0117","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4049-874X","authenticated-orcid":false,"given":"Aist\u0117","family":"\u017debrauskait\u0117","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dovil\u0117","family":"Petrikonyt\u0117","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Germanas","family":"Marinskis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigita","family":"Aidietien\u0117","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrius","family":"Aidietis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,23]]},"reference":[{"key":"503_CR1","doi-asserted-by":"crossref","unstructured":"Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893\u2013962.","DOI":"10.1093\/eurheartj\/ehw210"},{"issue":"5","key":"503_CR2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0002-9343(02)01253-6","volume":"113","author":"H Vidaillet","year":"2002","unstructured":"Vidaillet H, Granada JF, Chyou PH, Maassen K, Ortiz M, Pulido JN, et al. A population-based study of mortality among patients with atrial fibrillation or flutter. Am J Med. 2002;113(5):365\u201370.","journal-title":"Am J Med"},{"issue":"2","key":"503_CR3","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1161\/01.CIR.92.2.160","volume":"92","author":"LJ Collins","year":"1995","unstructured":"Collins LJ, Silverman DI, Douglas PS, Manning WJ. Cardioversion of Nonrheumatic Atrial Fibrillation. Circulation. 1995;92(2):160\u20133.","journal-title":"Circulation"},{"issue":"4","key":"503_CR4","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0735-1097(92)90530-Z","volume":"19","author":"AZ Arnold","year":"1992","unstructured":"Arnold AZ, Mick MJ, Mazurek RP, Loop FD, Trohman RG. Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter. J Am Coll Cardiol. 1992;19(4):851\u20135.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"503_CR5","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0002-9149(69)90068-X","volume":"23","author":"CJ Bjerkelund","year":"1969","unstructured":"Bjerkelund CJ, Orning OM. The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation. Am J Cardiol. 1969;23(2):208\u201316.","journal-title":"Am J Cardiol"},{"issue":"10","key":"503_CR6","first-page":"1467","volume":"17","author":"H Heidbuchel","year":"2015","unstructured":"Heidbuchel H, Verhamme P, Alings M, Antz M, Diener H-C, Hacke W, et al. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol. 2015;17(10):1467\u2013507.","journal-title":"Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol"},{"issue":"1","key":"503_CR7","first-page":"54","volume":"39","author":"H Shafeeq","year":"2014","unstructured":"Shafeeq H, Tran TH. New Oral Anticoagulants for Atrial Fibrillation. Pharm Ther. 2014;39(1):54\u201364.","journal-title":"Pharm Ther"},{"issue":"1","key":"503_CR8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.15420\/aer.2015.4.1.44","volume":"4","author":"P Bushoven","year":"2015","unstructured":"Bushoven P, Linzbach S, Vamos M, Hohnloser SH. Optimal Anticoagulation Strategy for Cardioversion in Atrial Fibrillation. Arrhythmia Electrophysiol Rev. 2015;4(1):44\u20136.","journal-title":"Arrhythmia Electrophysiol Rev"},{"issue":"1","key":"503_CR9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1046\/j.1365-2796.2003.01084.x","volume":"253","author":"J Ryman","year":"2003","unstructured":"Ryman J, Frick M, Frykman V, Rosenqvist M. Duration of warfarin sodium therapy prior to electrical cardioversion of atrial fibrillation. J Intern Med. 2003;253(1):76\u201380.","journal-title":"J Intern Med"},{"issue":"2","key":"503_CR10","volume":"5","author":"X Yao","year":"2016","unstructured":"Yao X, Abraham NS, Alexander GC, Crown W, Montori VM, Sangaralingham LR, et al. Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation. J Am Heart Assoc. 2016;5(2), e003074.","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"503_CR11","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0735-1097(02)01785-0","volume":"39","author":"K Seidl","year":"2002","unstructured":"Seidl K, Rameken M, Dr\u00f6gem\u00fcller A, Vater M, Brandt A, Schwacke H, et al. Embolic events in patients with atrial fibrillation and effective anticoagulation: value of transesophageal echocardiography to guide direct-current cardioversion. Final results of the Ludwigshafen Observational Cardioversion Study. J Am Coll Cardiol. 2002;39(9):1436\u201342.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"503_CR12","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jjcc.2011.06.009","volume":"58","author":"S Fukuda","year":"2011","unstructured":"Fukuda S, Watanabe H, Shimada K, Aikawa M, Kono Y, Jissho S, et al. Left atrial thrombus and prognosis after anticoagulation therapy in patients with atrial fibrillation. J Cardiol. 2011;58(3):266\u201377.","journal-title":"J Cardiol"},{"issue":"2","key":"503_CR13","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GYH Lip","year":"2010","unstructured":"Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137(2):263\u201372.","journal-title":"Chest"},{"issue":"5","key":"503_CR14","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","volume":"138","author":"R Pisters","year":"2010","unstructured":"Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJGM, Lip GYH. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010;138(5):1093\u2013100.","journal-title":"Chest"},{"key":"503_CR15","doi-asserted-by":"crossref","unstructured":"Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of, Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016;17(4):412.","DOI":"10.1093\/ehjci\/jew041"},{"issue":"8","key":"503_CR16","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016;18(8):891\u2013975.","journal-title":"Eur Heart J"},{"issue":"5","key":"503_CR17","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.amjcard.2014.12.016","volume":"115","author":"MM Zylla","year":"2015","unstructured":"Zylla MM, Pohlmeier M, Hess A, Mereles D, Kieser M, Bruckner T, et al. Prevalence of intracardiac thrombi under phenprocoumon, direct oral anticoagulants (dabigatran and rivaroxaban), and bridging therapy in patients with atrial fibrillation and flutter. Am J Cardiol. 2015;115(5):635\u201340.","journal-title":"Am J Cardiol"},{"issue":"2","key":"503_CR18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/CIRCULATIONAHA.110.977546","volume":"123","author":"R Nagarakanti","year":"2011","unstructured":"Nagarakanti R, Ezekowitz MD, Oldgren J, Yang S, Chernick M, Aikens TH, et al. Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion. Circulation. 2011;123(2):131\u20136.","journal-title":"Circulation"},{"issue":"11","key":"503_CR19","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jacc.2013.09.062","volume":"63","author":"G Flaker","year":"2014","unstructured":"Flaker G, Lopes RD, Al-Khatib SM, Hermosillo AG, Hohnloser SH, Tinga B, et al. Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation). J Am Coll Cardiol. 2014;63(11):1082\u20137.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"503_CR20","first-page":"1514","volume":"17","author":"A-K Johansson","year":"2015","unstructured":"Johansson A-K, Juhlin T, Engdahl J, Lind S, Hagwall K, Rorsman C, et al. Is one month treatment with dabigatran before cardioversion of atrial fibrillation sufficient to prevent thromboembolism? Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol. 2015;17(10):1514\u20137.","journal-title":"Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol"},{"issue":"19","key":"503_CR21","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/jama.2013.280521","volume":"310","author":"HS Abed","year":"2013","unstructured":"Abed HS, Wittert GA, Leong DP, Shirazi MG, Bahrami B, Middeldorp ME, et al. Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. JAMA. 2013;310(19):2050\u201360.","journal-title":"JAMA"},{"issue":"5","key":"503_CR22","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0735-1097(97)00019-3","volume":"29","author":"DL Dries","year":"1997","unstructured":"Dries DL, Rosenberg YD, Waclawiw MA, Domanski MJ. Ejection Fraction and Risk of Thromboembolic Events in Patients With Systolic Dysfunction and Sinus Rhythm: Evidence for Gender Differences in the Studies of Left Ventricular Dysfunction Trials. J Am Coll Cardiol. 1997;29(5):1074\u201380.","journal-title":"J Am Coll Cardiol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-017-0503-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T07:09:49Z","timestamp":1498374589000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-017-0503-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,23]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["503"],"URL":"https:\/\/doi.org\/10.1186\/s12872-017-0503-8","relation":{},"ISSN":["1471-2261"],"issn-type":[{"type":"electronic","value":"1471-2261"}],"subject":[],"published":{"date-parts":[[2017,2,23]]},"article-number":"67"}}